Renexxion
Renexxion, Inc. is a US-based biotechnology company with a wholly owned Irish subsidiary, dedicated to delivering innovative drugs for gastrointestinal disorders, notably with its pipeline drug Naronapride. The company focuses on high unmet needs in GI conditions and collaborates with strategic partners. Its leadership includes experienced biotech industry veterans committed to advancing pharmaceutical solutions.
Industries
Nr. of Employees
small (1-50)
Patents
Pharmaceutical formulations for the treatment of gastrointestinal disorders
US-12098149-B2
View DetailsStereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US-8138204-B2
View Details
Pharmaceutical formulations for the treatment of gastrointestinal disorders
US-12098149-B2
View DetailsStereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US-8138204-B2
View DetailsProducts
Oral GI prokinetic drug candidate
An orally administered small-molecule candidate developed for the treatment of gastrointestinal motility disorders; presented as a pill formulation.
Oral GI prokinetic drug candidate
An orally administered small-molecule candidate developed for the treatment of gastrointestinal motility disorders; presented as a pill formulation.
Services
Structuring and executing licensing and collaboration agreements with external pharmaceutical partners for clinical-stage assets.
Provision of informational content and resources covering gastrointestinal conditions.
Structuring and executing licensing and collaboration agreements with external pharmaceutical partners for clinical-stage assets.
Provision of informational content and resources covering gastrointestinal conditions.
Expertise Areas
- Clinical trial management
- Gastrointestinal drug development
- Regulatory strategy and interactions
- Preclinical pharmacology and translational research
Key Technologies
- Clinical trial design and execution (Phase II/III)
- Regulatory protocol agreement negotiation (e.g., SPA)
- Oral small-molecule formulation development
- Preclinical pharmacology and translational research methods